Importer

NPPA Issues Clarifications on Filing of Form-IA for New Drugs under the Drugs (Prices Control) Amendment Order, 2026

Posted by: Prabhas Chakraborty August 10, 2026

Debarment of Applicants Submitting Misleading, Fake, or Fabricated Documents under the Drugs Rules, 1945

Posted by: Hitesh Gupta August 10, 2026

Extension in date of implementation of IS 16102 (Part 1):2026

Posted by: Hitesh Gupta August 10, 2026

7
Comments Off on Extension in date of implementation of IS 16102 (Part 1):2026
10th August, 2026

Extension in date of implementation of Revised Standards for LED Luminaires

Posted by: Hitesh Gupta August 10, 2026

7
Comments Off on Extension in date of implementation of Revised Standards for LED Luminaires
10th August, 2026

Extension date for implementation of IS 18112 ‘Digital Television Receiver for satellite Broadcast Transmission Specification’

Posted by: Hitesh Gupta August 10, 2026

CDSCO Issues Revised Guidance on Common Submission Format for Import and Registration of Bulk Drugs and Finished Formulations in India

Posted by: Hitesh Gupta August 10, 2026

FSSAI Defers Earlier Coffee-Chicory Labelling Requirement and Issues Revised Front-of-Pack Declaration

Posted by: Prabhas Chakraborty July 29, 2026

CDSCO Releases Guidance Document on Medical Device Software

Posted by: Prabhas Chakraborty July 29, 2026

7
Comments Off on CDSCO Releases Guidance Document on Medical Device Software
29th July, 2026

What's New 2?

Regulation/Guidelines

The Cosmeceuticals Grey Zone: When a Cosmetic Claim Risks Becoming a Drug Claim

“Cosmeceutical” is a popular marketing word. It suggests something more powerful than an ordinary Cosmetic — a product that treats skin condition, not just improves appearance. The problem is that...

7th September, 2026

Regulation/Guidelines

Ingredient Safety Dossiers: Building a Defensible Package for Novel Actives

Companies developing Cosmetics with new or unusual active ingredients face a higher regulatory bar in India than those using well-established formulations. Understanding what “new” means under the Cosmetics Rules, 2020,...

2nd September, 2026

Regulation/Guidelines

Cosmetic Claims Substantiation: What Counts as Evidence Under Indian Rules

Walk down any Cosmetics aisle and you will see claims like “clinically proven,” “dermatologist tested,” or “reduces fine lines in two weeks.” These claims sell products — but under the...

26th August, 2026

Regulation/Guidelines

AI/ML-Based Medical Devices — Emerging Regulatory Questions

Traditional Medical Device regulation assumes a fixed product: what’s approved is what ships, indefinitely, until a formal change is filed and reviewed. Adaptive AI and machine learning algorithms break that...

24th August, 2026

Importer

Importer

NPPA Issues Clarifications on Filing of Form-IA for New Drugs under the Drugs (Prices Control) Amendment Order, 2026

Debarment of Applicants Submitting Misleading, Fake, or Fabricated Documents under the Drugs Rules, 1945

Extension in date of implementation of IS 16102 (Part 1):2026

Extension in date of implementation of Revised Standards for LED Luminaires

Extension date for implementation of IS 18112 ‘Digital Television Receiver for satellite Broadcast Transmission Specification’

CDSCO Issues Revised Guidance on Common Submission Format for Import and Registration of Bulk Drugs and Finished Formulations in India

FSSAI Defers Earlier Coffee-Chicory Labelling Requirement and Issues Revised Front-of-Pack Declaration

CDSCO Releases Guidance Document on Medical Device Software

For Importers To India

Drug

Biologicals

Food Supplements

Medical Device

IVD

Food

Cosmetic

Other

For Manufacturer in India

Drug

Biologicals

Food Supplements

Food

Medical Device

IVD

Cosmetic

Other